Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib Treatment

1. Parra-Guillen, Z.P.
2. Berger, P.B.
3. Haschke, M.
4. Donzelli, M.
5. Winogradova, D.
6. Pfister, B.
7. Früh, M.
8. Gillessen, S.
9. Krähenbühl, S.
10. Kloft, C.
11. Joerger, M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/BCPT.12801 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus